ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook

The following are excerpts from the newsletter

September 8, 1999

September 22, 1999

  • Use of peritoneal dialysis solution requires understanding of physiology behind process
  • Four-pronged error analysis is "best practice"
  • Safety Briefs:
    • In cooperation with the Medication Errors Division of FDA's Office of Postmarketing Drug Risk Assessment (OPDRA), Monarch Pharmaceuticals, a division of King Pharmaceuticals, has relabeled all strengths of KETALAR (ketamine) injection to reduce medication errors.

      Ketalar packaging

      Picture of new Ketalar packaging
    • Rather than develop or revise an approved list of medical abbreviations, JC allows you to deem a medical abbreviation dictionary as the standard. Still, for patient safety, you should have a list of dangerous abbreviations that should never be used.
    • FDA does not require companies to forward potential errors with product labeling, packaging, and names when reported by practitioners. To assure FDA, ISMP, and USP awareness, report to the USP-ISMP Medication Errors Reporting Program (800 23 ERROR) or FDA MEDWATCH Program (1-800-FDA-1088).
    • CDC has learned of numerous cases of inadequate treatment of syphilis with BICILLIN C-R (a mixture of 1.2 million units each of penicillin G benzathine and penicillin G procaine). Instead, BICILLIN (which contains only penicillin G benzathine) 2.4 million units should have been used.

subscribe now

Resources
Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Subscribe
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Long Term Care
Consumer
ISMP 17th Annual Cheers Awards
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2014 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP